18
Participants
Start Date
January 31, 2010
Primary Completion Date
November 21, 2018
Study Completion Date
November 21, 2018
StemEx
"For patients allocated to StemEx® arm:~* Day -20: Start small (or equal) portion expansion at processing site. (II) Conditioning Phase~* Day -6 to -1: Subject receives a RIC regimen containing Fludarabine, Cyclophosphamide and Total Body Irradiation (TBI) (III) Transplantation and Follow-up Phase~* Day 0: CBU unmanipulated portion transplantation (for StemEx® arm) or unmanipulated CBU transplantation.~* Day 1: StemEx® transplantation.~* Day 2 to 3 years: Post transplant follow-up."
Loyola University Medical Center, Maywood
Collaborators (1)
Gamida Cell ltd
INDUSTRY
Loyola University
OTHER